India’s tissue paper industry has received a significant boost with Jani Sales successfully commencing commercial production at its new PM 3 tissue paper machine.
The latest investment marks an important milestone in the company’s growth strategy and reinforces its commitment to strengthening domestic tissue manufacturing capabilities.
The commissioning of PM 3 is expected to substantially enhance the company’s production capacity, enabling it to cater to the growing demand for high-quality tissue products across household, institutional, hospitality, healthcare, and commercial segments. With the Indian tissue market witnessing steady expansion driven by increasing hygiene awareness, urbanization, and changing consumer lifestyles, the new machine places Jani Sales in a stronger position to meet evolving market requirements.
Industry observers view the project as a strategic move that not only expands manufacturing output but also improves operational efficiency and product consistency. The addition of PM 3 is expected to support the company’s efforts to offer a broader range of tissue grades while maintaining competitive supply capabilities in both domestic and export markets.
The investment reflects the broader trend of capacity expansion taking place within India’s paper and tissue sector, as manufacturers continue to modernize operations and adopt advanced technologies to improve productivity and sustainability. By bringing the new machine online, Jani Sales further strengthens its standing among the country’s prominent tissue paper producers and demonstrates confidence in the long-term growth prospects of the hygiene paper market.
As demand for tissue products continues to rise across various end-user sectors, the successful start-up of PM 3 represents another positive development for India’s paper industry, contributing to increased manufacturing capacity and supporting the sector’s ongoing modernization journey.